Showing results (31-40 of 47) with videos related to
Sort By:
Pageof 5
ACS Nano|July 30, 2010
Selectable spontaneous polarization direction and magnetic anisotropy in BiFeO3-CoFe2O4 epitaxial nanostructuresNico Dix, Rajaram Muralidharan, Jose-Manuel Rebled, et al.Clinical Biochemistry|October 25, 2011
Procalcitonin and C-reactive protein levels as diagnostic tools in febrile patients admitted to a General Internal Medicine wardRaul Ruiz-Esteban, Pilar Relea Sarabia, Emilio García Delgado, et al.Medicina Clinica|May 15, 2004
[Genotypic resistance to sulfamide drugs among patients with Pneumocystis jiroveci pneumonia]Enrique Calderón, Carmen de la Horra, Marco Antonio Montes-Cano, et al.Diabetes/Metabolism Research and Reviews|June 3, 2016
Glucose time series complexity as a predictor of type 2 diabetesCarmen Rodríguez de Castro, Luis Vigil, Borja Vargas, et al.Entropy (Basel, Switzerland)|April 23, 2022
Discriminating Bacterial Infection from Other Causes of Fever Using Body Temperature Entropy AnalysisBorja Vargas, David Cuesta-Frau, Paula González-López, et al.Entropy (Basel, Switzerland)|December 3, 2020
Model Selection for Body Temperature Signal Classification Using Both Amplitude and Ordinality-Based Entropy MeasuresDavid Cuesta-Frau, Pau Miró-Martínez, Sandra Oltra-Crespo, et al.International Journal of Chronic Obstructive Pulmonary Disease|May 23, 2020
Management of the COPD Patient with Comorbidities: An Experts Recommendation DocumentJesús Recio Iglesias, Jesús Díez-Manglano, Francisco López García, et al.Journal of Nanoscience and Nanotechnology|April 2, 2010
An investigation on solid state reactions in heat treated Au/Pd thin films for electrodes applicationsSoroush Nazarpour, Albert Cirera, Cesar Ferrater, et al.Diabetes/Metabolism Research and Reviews|January 10, 2020
Influence of glucometric 'dynamical' variables on duodenal-jejunal bypass liner (DJBL) anthropometric and metabolic outcomesAna Colás, Manuel Varela, Milos Mraz, et al.High Blood Pressure & Cardiovascular Prevention : the Official Journal of the Italian Society of Hypertension|September 26, 2018
Lowering Blood Pressure with the Combination of a Sodium-Glucose Cotransporter 2 Inhibitor and a Glucagon-like Peptide-1 Receptor Agonist in Type 2 Diabetic Patients: A Clinical EvidenceJosé Carlos Arévalo-Lorido, Juana Carretero Gómez, Ricardo Gómez Huelgas, et al.Pageof 5